Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler (Q32019428)

5 July 2017

Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler (English)

1 reference

5 July 2017

Noonan M

1

1 reference

5 July 2017

Karpel JP

2

1 reference

5 July 2017

Bensch GW

3

1 reference

5 July 2017

Ramsdell JW

4

1 reference

5 July 2017

Webb DR

5

1 reference

5 July 2017

Nolop KB

6

1 reference

5 July 2017

Lutsky BN

7

1 reference

5 July 2017

1 January 2001

1 reference

Annals of Allergy, Asthma & Immunology

5 July 2017

1 reference

5 July 2017

86

1 reference

5 July 2017

36-43

1 reference

5 July 2017

1

1 reference

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

5 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Measuring compliance with inhaled medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Nonadherence in asthmatic patients: is there a solution to the problem?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Mometasone furoate. A review of its intranasal use in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Circadian basis of the late asthmatic response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Timing of prednisone and alterations of airways inflammation in nocturnal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962353-8

7 January 2021

10.1016/S1081-1206(10)62353-8

Identifiers

DOI

1 reference

5 July 2017

1 reference